Viral Oncology Career Development Grant
病毒肿瘤学职业发展补助金
基本信息
- 批准号:6333297
- 负责人:
- 金额:$ 13.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-08 至 2006-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): I have reached a point in my career that
requires singular dedication to my area of interest, viral oncology. Since my
fellowship, I have been interested in lymphomas associated with viruses.
There are many patients with these diseases at our medical center. HIV
related lymphomas are common and Miami is an endemic area for HTLV-I
therefore, Adult T Cell Leukemia is frequently seen. We have one of the
largest organ transplant programs and there are many cases of post transplant
lymphoproliferative disease. My emphasis has been on experimental
therapeutics, specifically how certain viral lymphomas undergo apoptosis in
response to antiviral agents. This work has resulted in promising treatments
for viral lymphomas. I have continued to investigate the mechanisms of
activity of these agents in the clinic and in the laboratory. We have found
that distinct apoptotic pathways are activated by the antiviral agents
Azidothymidine and Interferon alpha in herpes-virus Lymphomas. We are now
investigating the cellular and viral factors which dictate sensitivity or
resistance. My other area of interest is training physicians in the area of
viral oncology. My training grant has allowed me to attract bright young
M.D.'s and M.D./Ph.D.'s to this field. Each of the fellows is studying a
specific area of viral oncology. Since Miami is the gateway to the Caribbean
and South America, I plan to develop collaborations with these areas hard hit
by AIDS and AIDS related cancers. I will also utilize a training program for
African physicians interested in viral oncology. We have established
infrastructures to undertake these tasks. The environment for career
development is excellent. My superiors have agreed to free me of all duties
unrelated to research, mentorship, and career development. Perhaps no other
medical center could offer such a diverse clinical population. I am supported
by clinical and basic peer reviewed funds and the cancer center as a program
leader. I have also developed collaborations with our top scientists to
further strengthen my program. My immediate career goal is to determine the
mechanisms to antiviral mediated apoptosis in AIDS Lymphomas and develop the
clinical and educational components of our viral oncology program. My long
term goal is to develop our viral oncology program to where we are recognized
for clinical care and research excellence and extend our studies to Latin
America and Africa. My role as mentor is ongoing.
描述(由申请人提供):我已经达到了我的职业生涯的一个点,
需要对我感兴趣的领域,病毒肿瘤学,做出特别的贡献 自从我
我一直对与病毒有关的淋巴瘤感兴趣。
在我们的医疗中心有许多患有这些疾病的患者。 艾滋病毒
相关的淋巴瘤是常见的,迈阿密是HTLV-1的流行区
因此,成人T细胞白血病是常见的。 我们有一个
最大的器官移植计划,有许多情况下,移植后
淋巴组织增生性疾病 我的重点是实验性的
治疗,特别是某些病毒性淋巴瘤如何经历细胞凋亡,
抗病毒药物的反应。 这项工作已经产生了有希望的治疗方法
治疗病毒性淋巴瘤 我一直在研究
这些药物在临床和实验室中的活性。 我们发现
抗病毒药物激活了不同的凋亡途径
疱疹病毒性淋巴瘤的叠氮胸苷和干扰素α。 我们现在
研究决定敏感性的细胞和病毒因素,或
阻力 我感兴趣的另一个领域是培训医生,
病毒肿瘤学 我的培训补助金让我能够吸引聪明的年轻人
M.D.和医学博士/博士到这个领域。 每个研究员都在研究一个
病毒肿瘤学的特定领域。 既然迈阿密是通往加勒比海的门户
和南美洲,我计划与这些遭受重创的地区发展合作关系,
艾滋病和艾滋病相关癌症。 我还将利用一个培训计划,
对病毒肿瘤学感兴趣的非洲医生。 我们建立
基础设施来完成这些任务。 职业环境
发展非常好。 我的上级已经同意免除我的一切职责
与研究、指导和职业发展无关。 也许没有其他
医疗中心可以提供如此多样化的临床人群。 我得到了支持
由临床和基本同行评审基金和癌症中心作为一个项目,
领袖 我还与我们的顶级科学家合作,
进一步加强我的计划。 我的职业目标是确定
艾滋病淋巴瘤中抗病毒介导的细胞凋亡的机制,并开发
我们的病毒肿瘤学项目的临床和教育部分。 我漫长
我们的长期目标是发展我们的病毒肿瘤学项目,
临床护理和研究卓越,并将我们的研究扩展到拉丁美洲
美洲和非洲。 我作为导师的角色还在继续。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William J Harrington其他文献
The use of high-dose azidothymidine in combination with chemotherapy upfront is an effective treatment approach for gamma-herpes virus-related non-Hodgkin’s lymphomas
- DOI:
10.1186/1750-9378-5-s1-a81 - 发表时间:
2010-10-11 - 期刊:
- 影响因子:2.800
- 作者:
Ulas Darda Bayraktar;Eileen Bernal;Lisa Cabral;William J Harrington;Dirk P Dittmer;Juan Carlos Ramos - 通讯作者:
Juan Carlos Ramos
William J Harrington的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William J Harrington', 18)}}的其他基金
Targeting of EBV Latency in Burkitt's Lymphoma
伯基特淋巴瘤中 EBV 潜伏期的靶向治疗
- 批准号:
7289830 - 财政年份:2006
- 资助金额:
$ 13.69万 - 项目类别:
Targeting of EBV Latency in Burkitt's Lymphoma
伯基特淋巴瘤中 EBV 潜伏期的靶向治疗
- 批准号:
7097879 - 财政年份:2006
- 资助金额:
$ 13.69万 - 项目类别:
Targeted Therapy for Burkitt Lymphoma in Resource Poor Settings
资源匮乏地区伯基特淋巴瘤的靶向治疗
- 批准号:
7288752 - 财政年份:2006
- 资助金额:
$ 13.69万 - 项目类别:
Targeted Therapy for Burkitt Lymphoma in Resource Poor Settings
资源匮乏地区伯基特淋巴瘤的靶向治疗
- 批准号:
7121431 - 财政年份:2006
- 资助金额:
$ 13.69万 - 项目类别:
Antiviral Mediated Apoptosis of Non-Hodgkin's Lymphoma
抗病毒介导的非霍奇金淋巴瘤细胞凋亡
- 批准号:
6734649 - 财政年份:2000
- 资助金额:
$ 13.69万 - 项目类别:
相似海外基金
Exploiting Metabolism to Uncloak Epstein-Barr Virus Immunogens in Latently Infected B-cells
利用代谢揭示潜伏感染 B 细胞中的 Epstein-Barr 病毒免疫原
- 批准号:
10889325 - 财政年份:2023
- 资助金额:
$ 13.69万 - 项目类别:
Epstein-Barr Virus nuclear antigen leader protein in transcription regulation
Epstein-Barr病毒核抗原前导蛋白在转录调控中的作用
- 批准号:
10829620 - 财政年份:2023
- 资助金额:
$ 13.69万 - 项目类别:
Project 4 - Controlling the Latent-to-Lytic Switch in Epstein-Barr Virus
项目 4 - 控制 Epstein-Barr 病毒中的潜伏至裂解转换
- 批准号:
10910338 - 财政年份:2023
- 资助金额:
$ 13.69万 - 项目类别:
Understanding the immune response changes to clinical interventions for Epstein-Barr virus infection prior to lymphoma development in children after organ transplants (UNEARTH)
了解器官移植后儿童淋巴瘤发展之前针对 Epstein-Barr 病毒感染的临床干预的免疫反应变化(UNEARTH)
- 批准号:
10755205 - 财政年份:2023
- 资助金额:
$ 13.69万 - 项目类别:
Regulation and Functions of the Epstein-Barr Virus Lytic Switch Protein
EB 病毒裂解开关蛋白的调控和功能
- 批准号:
489085 - 财政年份:2023
- 资助金额:
$ 13.69万 - 项目类别:
Operating Grants
Characterization of Epstein-Barr Virus Subversion of the Host SMC5/6 Restriction Pathway
Epstein-Barr 病毒颠覆宿主 SMC5/6 限制途径的特征
- 批准号:
10679118 - 财政年份:2023
- 资助金额:
$ 13.69万 - 项目类别:
Epstein Barr Virus Driven Mechanisms of Post Transplant Lymphoproliferative Disease
EB 病毒驱动的移植后淋巴增殖性疾病的机制
- 批准号:
10755055 - 财政年份:2023
- 资助金额:
$ 13.69万 - 项目类别:
Deciphering the Role of Epstein-Barr Virus Molecular Mimicry and B cell Transformation in Multiple Sclerosis
解读 Epstein-Barr 病毒分子拟态和 B 细胞转化在多发性硬化症中的作用
- 批准号:
10568864 - 财政年份:2023
- 资助金额:
$ 13.69万 - 项目类别:
Project 2: Novel investigation of Epstein-Barr virus as a potential cause of conjunctival squamous cell carcinoma among people living with HIV in Zimbabwe
项目 2:对 Epstein-Barr 病毒作为津巴布韦艾滋病毒感染者结膜鳞状细胞癌潜在原因的新调查
- 批准号:
10598376 - 财政年份:2023
- 资助金额:
$ 13.69万 - 项目类别:
Project 3 - Characterizing the Amplification Factories of Epstein-Barr Virus and Kaposi's Sarcoma-associated Herpesvirus
项目 3 - 描述 Epstein-Barr 病毒和卡波西肉瘤相关疱疹病毒的扩增工厂
- 批准号:
10910337 - 财政年份:2023
- 资助金额:
$ 13.69万 - 项目类别: